Silvio Danese

Rapid Symptomatic Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From TURANDOT and TURANDOT II

BACKGROUND: Treatment of ulcerative colitis (UC) aims to induce and maintain both endoscopic and symptomatic remission. While assessment of endoscopic remission is limited by timing of en...

Walter Reinisch ;

Silvio Danese ;

Xavier Hebuterne ;

Maria Kopocka ;

Dino Tarabar ;

Tomas Valasek ;

Milos Gregus ;

William J. Sandborn , MD;

Paul Hellstern ;

Kim Joo Sung ;

Miles Sparrow ;

Kenneth Gorelick ;

Michael Hoy ;

Martina Goetsch ;

12/12/2019

Risankizumab Versus Ustekinumab in Patients With Moderate to Severe Crohn’s Disease: Results From the Phase 3B SEQUENCE Trial

1 Nancy University Hospital, Vandoeuvre-les-Nancy, France; 2 GI Alliance, United States; 3 Icahn School of Medicine at Mount Sinai, New York, United States; 4 UNIMI, Department of Pathoph...

Xiu Huang ;

Sofie Berg ;

Lei Shu ;

Kristina Kligys ;

Remo Panaccione ;

Marc Ferrante ;

Britta Siegmund ;

Jean-Frederic Colombel ;

Ezequiel Neimark ;

Geert D'Haens ;

Kori Wallace ;

Marla C. Dubinsky , MD;

Peter Irving ;

W. Rachel Duan ;

Flavio Caprioli ;

Stefan Schreiber ;

Laurent Peyrin-Biroulet ;

Raja Atreya ;

Silvio Danese ;

James O. Lindsay ;

Casey Chapman ;

Peter Bossuyt ;

Toni Anschutz ;

Valerie Pivorunas ;

01/11/2024

Efficacy and Safety of Icanbelimod (CBP-307) in Adults With Moderate to Severe Ulcerative Colitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial

1 Peking Union Medical College Hospital, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China; 2 The Affiliated Hospital of Qingdao University, Qingdao, Qingda...

Feng Xu ;

Jiaming Qian ;

Zibin Tian ;

Yanqing Li ;

Fangyu Wang ;

Xiaolan Zhang ;

Hong Yang ;

David T. Rubin , MD;

Jiawang Guo ;

Wubin Pan ;

Brian G. Feagan ;

Raul Collazo ;